Skip to content

The Role of FAPI PET-CT in Diagnosing Endometriosis

Use of Fibroblast Activation Protein Inhibitor (FAPI) PET-CT Before Surgery in Patient with Endometriosis

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06792318
Enrollment
30
Registered
2025-01-24
Start date
2025-03-31
Completion date
2027-06-30
Last updated
2025-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Keywords

endometriosis, PET CT, Fibroblast activation protein inhibitor

Brief summary

Patients with suspected endometriosis scheduled for surgery will be identified. They will be asked to participate in a study evaluating the feasibility of FAPI PET-CT in diagnosing endometriosis. The results will be compared with surgical findings, pathology, and other imaging techniques if available (i.e., MRI, US).

Detailed description

This study investigates FAPI PET-CT imaging in endometriosis diagnosis using a standardized protocol. Participants will undergo two imaging sessions after a single FAPI injection: First Session: Initial scan at 10 minutes post-injection Follow-up scan at 30 minutes Second Session: Additional scans at 60 and 80 minutes post-injection The protocol is designed to minimize radiation exposure through: Single FAPI injection Two ultra-low dose CT scans Limited field of view to suspected areas. Nuclear medicine physicians will review PET-CT images independently, blinded to other imaging findings (MRI, US). Results will be shared with surgeons to guide the removal of suspicious lesions during surgery. All removed tissue will undergo pathological examination for confirmation. The study incorporates safety monitoring: Observation during and after FAPI administration Follow-up contact at 24-48 hours post-scan Documentation of any adverse events Immediate reporting of unexpected findings. This research could potentially provide evidence for a novel, non-invasive method to comprehensively map endometriotic lesions, improving pre-operative planning.

Interventions

DIAGNOSTIC_TESTFAPI PET-CT

FAPI PET-CT imaging protocol: Single dose 68Ga/18F-FAPI (2 MBq/kg) Two imaging sessions: First: 10 and 30 minutes post-injection Second: 60 and 80 minutes post-injection Ultra-low dose CT for attenuation correction and anatomical localization

Sponsors

Ziv Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

Open label study. The surgeon operates based on PET-CT findings, and the pathologist examines specimens from lesions detected on PET-CT

Intervention model description

All participants undergo FAPI PET-CT imaging followed by laparoscopic surgery. Surgical specimens are sent for pathological confirmation of PET-CT findings. This single-group diagnostic study aims to evaluate the accuracy of FAPI PET-CT in detecting endometriosis lesions using surgical and pathological findings as the gold standard.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Female participants aged 18-45 years * Clinical suspicion of endometriosis based on symptoms * Scheduled for diagnostic/therapeutic laparoscopic surgery * Ability to understand and provide written informed consent * Completed and signed Radiation Exposure Documentation Form

Exclusion criteria

* Pregnant women or women who are breastfeeding * History of pelvic radiation therapy * Known active malignancy * Exposure to ionizing radiation for medical purposes within 12 months prior to enrollment

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic Accuracy of FAPI PET-CT in Endometriosis DetectionWithin 1 month post-surgeryAssessment of FAPI PET-CT diagnostic performance through calculation of sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Surgical findings with histological confirmation will serve as the reference standard for evaluation.

Secondary

MeasureTime frameDescription
Comparison of FAPI PET-CT with Conventional ImagingWithin 1 month post-surgeryEvaluation of FAPI PET-CT's ability to detect endometriotic lesions not visible on conventional imaging (TVUS and MRI). Comparison includes identification of additional lesions and assessment of anatomical distribution of detected lesions.

Countries

Israel

Contacts

Primary ContactIsrael Sandler, MD
israels@ziv.gov.il+972-527-362280

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026